Suppr超能文献

COVID-19 病理生理学中的细胞因子风暴:miRNAs 可能出现的功能紊乱。

Cytokine storm in the pathophysiology of COVID-19: Possible functional disturbances of miRNAs.

机构信息

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

Department of Immunology, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Int Immunopharmacol. 2021 Dec;101(Pt A):108172. doi: 10.1016/j.intimp.2021.108172. Epub 2021 Sep 21.

Abstract

SARS-CoV-2, as the causative agent of COVID-19, is an enveloped positives-sense single-stranded RNA virus that belongs to the Beta-CoVs sub-family. A sophisticated hyper-inflammatory reaction named cytokine storm is occurred in patients with severe/critical COVID-19, following an imbalance in immune-inflammatory processes and inhibition of antiviral responses by SARS-CoV-2, which leads to pulmonary failure, ARDS, and death. The miRNAs are small non-coding RNAs with an average length of 22 nucleotides which play various roles as one of the main modulators of genes expression and maintenance of immune system homeostasis. Recent evidence has shown that Homo sapiens (hsa)-miRNAs have the potential to work in three pivotal areas including targeting the virus genome, regulating the inflammatory signaling pathways, and reinforcing the production/signaling of IFNs-I. However, it seems that several SARS-CoV-2-induced interfering agents such as viral (v)-miRNAs, cytokine content, competing endogenous RNAs (ceRNAs), etc. preclude efficient function of hsa-miRNAs in severe/critical COVID-19. This subsequently leads to increased virus replication, intense inflammatory processes, and secondary complications development. In this review article, we provide an overview of hsa-miRNAs roles in viral genome targeting, inflammatory pathways modulation, and IFNs responses amplification in severe/critical COVID-19 accompanied by probable interventional factors and their function. Identification and monitoring of these interventional elements can help us in designing the miRNAs-based therapy for the reduction of complications/mortality rate in patients with severe/critical forms of the disease.

摘要

SARS-CoV-2 作为 COVID-19 的病原体,是一种包膜的正链单链 RNA 病毒,属于 Beta-CoVs 亚科。在严重/危重新冠肺炎患者中,发生了一种称为细胞因子风暴的复杂超炎症反应,这是由于 SARS-CoV-2 引起的免疫炎症过程失衡和抗病毒反应抑制,导致肺衰竭、ARDS 和死亡。miRNAs 是平均长度为 22 个核苷酸的小非编码 RNA,作为基因表达的主要调节剂之一和免疫系统稳态的维持者,发挥着各种作用。最近的证据表明,人类(hsa)-miRNAs 具有在三个关键领域发挥作用的潜力,包括靶向病毒基因组、调节炎症信号通路和增强 IFN-I 的产生/信号。然而,似乎有几种 SARS-CoV-2 诱导的干扰因子,如病毒(v)-miRNAs、细胞因子含量、竞争内源 RNA(ceRNA)等,会妨碍 hsa-miRNAs 在严重/危重新冠肺炎中的有效功能。这会导致病毒复制增加、炎症过程加剧和继发并发症的发展。在这篇综述文章中,我们概述了 hsa-miRNAs 在严重/危重新冠肺炎中靶向病毒基因组、调节炎症通路和放大 IFN 反应的作用,以及可能的干预因素及其功能。鉴定和监测这些干预因素有助于我们设计基于 miRNAs 的治疗方法,以降低严重/危重症患者的并发症/死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0acd/8452524/ee1c9ff7677c/gr1a_lrg.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验